Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Poster Presentations: Diabetes, Obesity and Metabolism

Diabetes therapy

Previous section
Diabetes complications
Table of contents
Next section
Endocrine Disruptors

ea0056p476 | Diabetes therapy

Analysis of safety and efficacy of liraglutide compared with dulaglutide in patients with type 2 diabetes mellitus

ea0056p477 | Diabetes therapy

A localized painfull rash induced by linagliptin in a patient with type 2 diabetes

ea0056p478 | Diabetes therapy

Preservation of residual β-insulin function in a patient with a type 1 diabetes treated early by fingolimod for multiple sclerosis

ea0056p479 | Diabetes therapy

Treating depression in insulin dependant diabetics improves glucoregulation

ea0056p480 | Diabetes therapy

Comparative analisis of multiple daily injection of insulin and continuous subcutaneous insulin infusion regimes in children and adolescents with type 1 DM in Uzbekistan

ea0056p481 | Diabetes therapy

Perinatal outcomes in Mexican women with mild gestational diabetes mellitus without treatment diagnosed by the international association of diabetes and pregnancy study groups criteria

ea0056p482 | Diabetes therapy

Meta-analysis of clinical efficacy of traditional chinese medicine formula (Simiao Yong’an Decoction) in treatment of diabetic foot meta-analysis of clinical efficacy of traditional chinese medicine formula (Simiao Yong’an Decoction) in treatment of diabetic foot

ea0056p483 | Diabetes therapy

Maculopapular rash developed after initiation of U-300 glargine insulin in a patient with type 1 diabetes mellitus

ea0056p484 | Diabetes therapy

Dapagliflozin after liraglutide in patients with type 2 diabetes

ea0056p485 | Diabetes therapy

Canagliflozin after liraglutide in patients with type 2 diabetes

ea0056p486 | Diabetes therapy

Inhibitors SGLT2 after liraglutide in patients with type 2 diabetes

ea0056p487 | Diabetes therapy

Second setp in type 2 diabetes, what to choose?

ea0056p488 | Diabetes therapy

Short term adherence with discharge recommendation for insulin treatment among patients with type 2 diabetes

ea0056p489 | Diabetes therapy

Dulaglutide; effectiveness in a real world population with type 2 diabetes

ea0056p490 | Diabetes therapy

Experience in clinical practice with new long-acting insulins in type 2 diabetes (T2D)

ea0056p491 | Diabetes therapy

Six months of retrospective glycemic control and anthropometric outcomes in type 2 diabetic patients with new dapagliflozin treatment; actual clinical experience data from single center

ea0056p492 | Diabetes therapy

Can patient profile influence on GLP1 analogues prescription among physicians?: patient selection and perspectives

ea0056p493 | Diabetes therapy

SGLT-2 inhibitors or GLP-1 receptor agonists as add-on to insulin therapy in patients with type 2 diabetes: comparative analysis

ea0056p494 | Diabetes therapy

Clinical predictors of therapeutic response to SGLT-2 inhibitors

ea0056p495 | Diabetes therapy

Improvement control rate of blood glucose/blood pressure/blood lipid in diabetes patients by hospital-community integrated management in Shanghai

ea0056p496 | Diabetes therapy

Abstract unavailable

ea0056p497 | Diabetes therapy

A case with metformin overdose associated acidosis

ea0056p498 | Diabetes therapy

Cognitive status, anxiety and depression in patients with type 2 diabetes mellitus on selective DPP4 inhibitor therapy

ea0056p499 | Diabetes therapy

Metabolic effects of liraglutide in type 2 diabetic patients.

ea0056p500 | Diabetes therapy

Efficacy of glucose control on a combination of dapagliflozin in people with type 2 diabetes mellitus in Korea

ea0056p501 | Diabetes therapy

Comparison of occurrence of fasting hyperinsulinemia according to type of insulin analogs

ea0056p502 | Diabetes therapy

The impact of different glucose-lowering regimens on cardiovascular disease in type 2 diabetes

ea0056p503 | Diabetes therapy

Evaluation of the risk of hypoglycemias using a questionnaire in patients with type 2 diabetes

ea0056p504 | Diabetes therapy

The intensity of metabolic processes due to different variants of polymorphism rs1801282 Pro12Ala of the PPARG gene in patients with diabetes mellitus type 2

ea0056p505 | Diabetes therapy

A latent autoimmune diabetes in adults (LADA) case renamed after six years of diabetes diagnosis when complicated with diabetic ketoacidosis induced by dapagliflozin

ea0056p506 | Diabetes therapy

Awareness of patients with diabetes on the disease

ea0056p507 | Diabetes therapy

Efficacy in metabolic control and weight loss of combined treatment with GLP-1 receptor analogues and SGLT-2 inhibitors

ea0056p508 | Diabetes therapy

Insulin requirements and obstetric outcomes in pregnant woment with type 1 diabetes under continuous subcutaneous insulin infusion (CSII)

ea0056p509 | Diabetes therapy

Addition of sodium-glucose co-transporter type 2 inhibitors to diabetic patients type 2 in treatment with glucagon-like peptide-1 agonists: clinical results

ea0056p510 | Diabetes therapy

Psychopathological determinants of enhanced quality of life in continuous subcutaneous insulin infusion therapy

ea0056p511 | Diabetes therapy

Effects of opuntia ficus-indica plant extract ingestion on glucose and insulin plasma levels during oral glucose tolerance test

ea0056p512 | Diabetes therapy

Predictive factors of starting insulin in gestational diabetes’ Management: About 191 cases

ea0056p513 | Diabetes therapy

Safety and efficacy of different insulin regimens in treatment of type 2 diabetic patients who insist to fast during Ramadan 1437 (Hijri) In Fayoum Governorate, Egypt

ea0056p514 | Diabetes therapy

Pregnancy and diabetes: an overview about 144 patients

ea0056p515 | Diabetes therapy

Moroccan woman pregnant diabetic: what dietary errors? About 60 cases

ea0056p516 | Diabetes therapy

The flexible insulin therapy: satisfaction after the change of treatment? About 73 cases

ea0056p517 | Diabetes therapy

Long-term results of continuous subcutaneous insulin infusion on glycemic control and severe hypoglycemias

ea0056p518 | Diabetes therapy

The anxiety and depression disorders in the diabetic type 1 (preliminary results)

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more